{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:03:03Z","timestamp":1793073783627,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T00:00:00Z","timestamp":1211241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2407-8-140","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T18:14:25Z","timestamp":1212689665000},"source":"Crossref","is-referenced-by-count":67,"title":["Spectrum and characterisation of BRCA1 and BRCA2deleterious mutations in high-risk Czech patients with breast and\/or ovarian cancer"],"prefix":"10.1186","volume":"8","author":[{"given":"Eva","family":"Machackova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Foretova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirka","family":"Lukesova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Vasickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Navratilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Coene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Pavlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Kosinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Kuklova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,20]]},"reference":[{"key":"1078_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1897-4287-4-1-3","volume":"4","author":"L Foretova","year":"2006","unstructured":"Foretova L, Petrakova K, Palacova M, Kalabova R, Navratilova M, Lukesova M, Vasickova P, Machackova E, Kleibl Z, Pohlreich P: Genetic and preventive services for hereditary breast and ovarian cancer in the Czech Republic. Hereditary Cancer in Clinical Practice. 2006, 4: 3-6.","journal-title":"Hereditary Cancer in Clinical Practice"},{"key":"1078_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00109-005-0696-7","volume":"84","author":"MP Lux","year":"2006","unstructured":"Lux MP, Fasching PA, Beckmann MW: Hereditary breast and ovarian cancer: review and future perspectives. J Mol Med. 2006, 84: 16-28. 10.1007\/s00109-005-0696-7.","journal-title":"J Mol Med"},{"key":"1078_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998, 62: 676-689. 10.1086\/301749.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1078_CR4","first-page":"265","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995, 56 (1): 265-271.","journal-title":"Am J Hum Genet"},{"key":"1078_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Rish HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallopniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003, 72: 1117-1130. 10.1086\/375033.","journal-title":"Am J Hum Genet"},{"key":"1078_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrc726","volume":"2","author":"SA Narod","year":"2002","unstructured":"Narod SA: Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer. 2002, 2: 113-123. 10.1038\/nrc726.","journal-title":"Nat Rev Cancer"},{"key":"1078_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ng1294-399","volume":"8","author":"LS Friedman","year":"1994","unstructured":"Friedman LS, Ostermeyer EA, Szabo CI, Down P, Lynch ED, Rowel SE, King MC: Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet. 1994, 8: 399-404. 10.1038\/ng1294-399.","journal-title":"Nat Genet"},{"key":"1078_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng1196-253","volume":"14","author":"S Mazoyer","year":"1996","unstructured":"Mazoyer S, Dunning AM, Serova O, Dearden J, Puget A, Healey CS, Gayther SA, Mangion J, Stratton MR, Lynch HT, Goldgar DE, Ponder BAJ, Lenoir GM: A polymorphic stop codon in BRCA2. Nat Genet. 1996, 14: 253-254. 10.1038\/ng1196-253.","journal-title":"Nat Genet"},{"key":"1078_CR9","doi-asserted-by":"publisher","first-page":"13920","DOI":"10.1073\/pnas.96.24.13920","volume":"96","author":"BH Spain","year":"1999","unstructured":"Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma IM: Truncated BRCA2 is cytoplasmic: Implications for cancer-linked mutations. Proc Natl Acad Sci USA. 1999, 96: 13920-13925. 10.1073\/pnas.96.24.13920.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1078_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/(SICI)1096-8628(19981102)80:2<140::AID-AJMG10>3.0.CO;2-L","volume":"80","author":"JD Hoffman","year":"1998","unstructured":"Hoffman JD, Hallam SE, Venne VL, Lyon E, Ward K: Implications of a novel cryptic splice site in the BRCA1 gene. Am J Med Genet. 1998, 80: 140-144. 10.1002\/(SICI)1096-8628(19981102)80:2<140::AID-AJMG10>3.0.CO;2-L.","journal-title":"Am J Med Genet"},{"key":"1078_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gcc.10221","volume":"37","author":"K Claes","year":"2003","unstructured":"Claes K, Poppe B, Machackova E, Coene I, Foretova L, De Paepe A, Messiaen L: Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes Chromosomes Cancer. 2003, 37: 314-320. 10.1002\/gcc.10221.","journal-title":"Genes Chromosomes Cancer"},{"key":"1078_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.mrfmmm.2004.07.024","volume":"573","author":"T Judkins","year":"2005","unstructured":"Judkins T, Hendricson BC, Deffenbaugh AM, Scholl T: Single nucleotide polymorphisms in clinical genetic testing: The characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1. Mutation Research. 2005, 573: 168-179.","journal-title":"Mutation Research"},{"key":"1078_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M","volume":"13","author":"K Claes","year":"1999","unstructured":"Claes K, Machackova E, De Vos M, Mortier G, De Paepe A, Messiaen L: Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6\/16 Flemish families with breast and\/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Hum Mutat. 1999, 13: 256-10.1002\/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M.","journal-title":"Hum Mutat"},{"key":"1078_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2350-8-32","volume":"8","author":"P Vasickova","year":"2007","unstructured":"Vasickova P, Machackova E, Lukesova M, Damborsky J, Horky O, Pavlu H, Kuklova J, Kosinova V, Navratilova M, Foretova L: High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. BMC Med Genet. 2007, 8: 32-10.1186\/1471-2350-8-32.","journal-title":"BMC Med Genet"},{"key":"1078_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/mutage\/10.3.189","volume":"10","author":"MR O'Donovan","year":"1995","unstructured":"O'Donovan MR, Freemantle MR, Hull G, Bell DA, Arlett CF, Cole J: Extended-term cultures of human T-lymphocytes: a practical alternative to primary human lymphocytes for use in genotoxicity testing. Mutagenesis. 1995, 10: 189-201. 10.1093\/mutage\/10.3.189.","journal-title":"Mutagenesis"},{"key":"1078_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O","volume":"11","author":"SE Antonarakis","year":"1998","unstructured":"Antonarakis SE, the Nomenclature Working Group: Recommendations for a nomenclature system for human gene mutations. Hum Mutat. 1998, 11: 1-3. 10.1002\/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O.","journal-title":"Hum Mutat"},{"key":"1078_CR17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ijc.1626","volume":"97","author":"A Meindl","year":"2002","unstructured":"Meindl A, German Consortium for Hereditary Breast and Ovarian Cancer: Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer. 2002, 97: 472-480. 10.1002\/ijc.1626.","journal-title":"Int J Cancer"},{"key":"1078_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/sj.bjc.6601656","volume":"90","author":"K Claes","year":"2004","unstructured":"Claes K, Poppe B, Coene I, Paepe AD, Messiaen L: BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast\/ovarian cancer families. Br J Cancer. 2004, 90: 1244-51. 10.1038\/sj.bjc.6601656.","journal-title":"Br J Cancer"},{"key":"1078_CR19","doi-asserted-by":"publisher","first-page":"41399","DOI":"10.1074\/jbc.M106551200","volume":"276","author":"PS Brzovic","year":"2001","unstructured":"Brzovic PS, Meza JE, King MC, Klevit RE: BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions. J Biol Chem. 2001, 276: 41399-41406. 10.1074\/jbc.M106551200.","journal-title":"J Biol Chem"},{"key":"1078_CR20","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1073\/pnas.081068398","volume":"98","author":"H Ruffner","year":"2001","unstructured":"Ruffner H, Joazeiro CAP, Hemmati D, Hunter T, Verma IM: Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. PNAS. 2001, 98: 5134-5139. 10.1073\/pnas.081068398.","journal-title":"PNAS"},{"key":"1078_CR21","unstructured":"Breast Cancer Information Core Database. [ http:\/\/research.nhgri.nih.gov\/bic\/ ]"},{"key":"1078_CR22","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1086\/302922","volume":"66","author":"B Gorski","year":"2000","unstructured":"Gorski B, Byrski T, Huzarski T, Lakubowska A, Menkiszak J, Gronwald J, Pluzanska A, Babenek M, Fisher-Maliszewska L, Grzybowska E, Narod SA, Lubinski J: Founder mutations in the BRCA1 gene in Polish families with breast-ovarian Cancer. Am J Hum Genet. 2000, 66: 1963-1968. 10.1086\/302922.","journal-title":"Am J Hum Genet"},{"key":"1078_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","volume":"4","author":"MG Reese","year":"1997","unstructured":"Reese MG, Eeckman FH, Kulp D, Haussler D: Improved splice site detection in Genie. J Comput Biol. 1997, 4: 311-323.","journal-title":"J Comput Biol"},{"key":"1078_CR24","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1006\/jmbi.2001.4561","volume":"307","author":"LJ Fang","year":"2001","unstructured":"Fang LJ, Simard MJ, Vidaud D, Assouline B, Lemieux B, Vidaud M, Chabot B, Thirion JP: A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition. J Mol Biol. 2001, 307: 1261-70. 10.1006\/jmbi.2001.4561.","journal-title":"J Mol Biol"},{"key":"1078_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1089\/gte.2006.10.116","volume":"10","author":"M Thomassen","year":"2006","unstructured":"Thomassen M, Kruse TA, Jensen PK, Gerdes AM: A missense mutation in exon 13 in BRCA2, c.7235G>A, results in skipping of exon 13. Genet Test. 2006, 10: 116-120. 10.1089\/gte.2006.10.116.","journal-title":"Genet Test"},{"key":"1078_CR26","first-page":"83","volume":"84","author":"I Bieche","year":"1997","unstructured":"Bieche I, Lidereau R: Somatic genetics of breast cancer. Bull Cancer. 1997, 84: 83-96.","journal-title":"Bull Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-8-140\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T13:19:44Z","timestamp":1468070384000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-8-140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,20]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-8-140","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,20]]},"article-number":"140"}}